BioXcel Therapeutics, Inc. (BTAI)
1.315
+0.10
(+7.79%)
USD |
NASDAQ |
May 27, 16:00
1.31
0.00 (0.00%)
After-Hours: 18:43
BioXcel Therapeutics Cash from Investing (Quarterly) : 0.00 for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Verastem, Inc. | -16.02M |
| Quince Therapeutics, Inc. | 12.00M |
| ACADIA Pharmaceuticals, Inc. | 66.28M |
| Alnylam Pharmaceuticals, Inc. | -25.54M |
| Amgen, Inc. | -716.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -11.81M |
| Cash from Financing (Quarterly) | 0.232M |
| Free Cash Flow | -57.38M |
| Free Cash Flow Per Share (Quarterly) | -0.501 |
| Free Cash Flow to Equity (Quarterly) | 7.311M |
| Free Cash Flow to Firm (Quarterly) | -7.611M |
| Free Cash Flow Yield | -301.9% |